- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/25 - Herpesvirus varicellae
Détention brevets de la classe A61K 39/25
Brevets de cette classe: 220
Historique des publications depuis 10 ans
|
9
|
10
|
15
|
10
|
14
|
18
|
18
|
27
|
22
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Xiamen University | 533 |
13 |
| Glaxosmithkline Biologicals S.A. | 1635 |
11 |
| Modernatx, Inc. | 1260 |
8 |
| Xiamen Innovax Biotech Co., Ltd. | 89 |
7 |
| Northwestern University | 3366 |
6 |
| Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | 28 |
6 |
| Mogam Institute for Biomedical Research | 71 |
6 |
| Board of Regents of the University of Nebraska | 754 |
5 |
| Institute for Research in Biomedicine | 98 |
4 |
| Rutgers, The State University of New Jersey | 1880 |
4 |
| Merck Sharp & Dohme Corp. | 2201 |
3 |
| Merck Patent GmbH | 5850 |
3 |
| Adjuvance Technologies, Inc., AKA Adjuvance | 22 |
3 |
| Celltrion, Inc. | 324 |
3 |
| Dynavax Technologies Corporation | 116 |
3 |
| Eyegene, Inc. | 34 |
3 |
| Icahn School of Medicine at Mount Sinai | 936 |
3 |
| Oxford University Innovation Limited | 1503 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
3 |
| Changchun BCHT Biotechnology Co. | 19 |
3 |
| Autres propriétaires | 120 |